Society for Immunotherapy of Cancer (SITC) Symposium: Mechanisms of Resistance to Immunotherapy

13 May 2017
8:00 AM – 10:00 AM
Room 207A

Society for Immunotherapy of Cancer (SITC) Symposium: Mechanisms of Resistance to Immunotherapy

Chairs:
Michael B. Atkins, Georgetown Lombardi Comprehensive Cancer Ctr.
Mario Sznol, Yale Sch. of Med.

Speakers:

  • Steven A. Rosenberg, NCI, NIH, Characterizing tumor-specific T cell responses in tumors with low mutation rates
  • Roger S. Lo, Univ. of California, Los Angeles, Pathway and mutation analyses in melanoma tumors resistant to anti-PD-1
  • Ira Mellman, Genentech, Insights into mechanisms of immune cell antagonism by PD-1 engagement in animal models
  • Louis M. Weiner, Georgetown Lombardi Comprehensive Cancer Ctr., Use of shRNA screens to identify novel immune checkpoints
  • Carla V. Rothlin, Yale Univ., Role of receptor tyrosine kinases in function of intratumoral monocytes and macrophages
  • Nicholas P. Restifo, NCI, NIH, Role of oxygen in immunosuppression